Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology

por Kagey, Michael H, He, Xi
Publicado 2017

A Role for Non-Covalent SUMO Interaction Motifs in Pc2/CBX4 E3 Activity

por Merrill, Jacqueline C., Melhuish, Tiffany A., Kagey, Michael H., Yang, Shen-Hsi, Sharrocks, Andrew D., Wotton, David
Publicado 2010

Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors

por Caldwell, Charles, Rottman, James B., Paces, Will, Bueche, Elizabeth, Reitsma, Sofia, Gibb, Joseph, Adisetiyo, Vitria, Haas, Michael S., Heath, Heidi, Newman, Walter, Baum, Jason, Gianani, Roberto, Kagey, Michael H.
Publicado 2021

Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers

por Klempner, Samuel J., Bendell, Johanna C., Villaflor, Victoria Meucci, Tenner, Laura LaNiel, Stein, Stacey M., Rottman, James B., Naik, Girish S., Sirard, Cynthia A., Kagey, Michael H., Chaney, Marya F., Strickler, John H.
Publicado 2021

Mediator and Cohesin Connect Gene Expression and Chromatin Architecture

por Kagey, Michael H., Newman, Jamie J., Bilodeau, Steve, Zhan, Ye, Orlando, David A., van Berkum, Nynke L., Ebmeier, Christopher C., Goossens, Jesse, Rahl, Peter B., Levine, Stuart S., Taatjes, Dylan J., Dekker, Job, Young, Richard A.
Publicado 2010

DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01

por Jarman, Edward J., Horcas‐Lopez, Marta, Waddell, Scott H., MacMaster, Stephanie, Gournopanos, Konstantinos, Soong, Daniel Y. H., Musialik, Kamila I., Tsokkou, Panagiota, Ng, Minn‐E, Cambridge, William A., Wilson, David H., Kagey, Michael H., Newman, Walter, Pollard, Jeffrey W., Boulter, Luke
Publicado 2022